CARDIOLOGY / RESEARCH LETTER
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Insulin-like growth factor-1 (IGF-1) promotes survival and inhibits cardiac autophagy disruption.

Methods:
Male Wistar rats were treated with IGF-1 (50 µg/kg), and 24 h after injection hearts were excised. The level of interaction between Beclin-1 and the α1 subunit of sodium/potassium-adenosine triphosphates (Na+/K+-ATPase), and phosphorylated forms of IGF-1 receptor/insulin receptor (IGF-1R/IR), forkhead box protein O1 (FOXO1) and AMP-activated protein kinase (AMPK) were measured.

Results:
The results indicate that IGF-1 decreased Beclin-1’s association with Na+/K+-ATPase (p < 0.05), increased IGF-1R/IR and FOXO1 phosphorylation (p < 0.05), and decreased AMPK phosphorylation (p < 0.01) in rats’ hearts.

Conclusions:
The new IGF-1 therapy may control autosis and minimize cardiomyocyte mortality.

 
REFERENCES (15)
1.
Liang W, Gustafsson ÅB. Recent insights into the role of autophagy in the heart. Curr Op Physiol 2022; 29: 100593.
 
2.
Ikeda S, Zablocki D, Sadoshima J. The role of autophagy in death of cardiomyocytes. J Mol Cell Cardiol 2022; 165: 1-8.
 
3.
Fernández ÁF, Liu Y, Ginet V, et al. Interaction between the autophagy protein Beclin 1 and Na+,K+-ATPase during starvation, exercise, and ischemia. JCI Insight 2020; 5: e133282.
 
4.
Liu Y, Shoji-Kawata S, Sumpter RM Jr, et al. Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc Nat Acad Sci USA 2013; 110: 20364-71.
 
5.
Standley PR, Zhang F, Zayas RM, et al. IGF-I regulation of Na(+)-K(+)-ATPase in rat arterial smooth muscle. Am J Physiol 1997; 273: E113-21.
 
6.
Isenovic ER, Meng Y, Jamali N, Milivojevic N, Sowers JR. Ang II attenuates IGF-1-stimulated Na+, K+-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells. Int J Mol Med 2004; 13: 915-22.
 
7.
Xu Y, Margetts MB, Venugopal H, et al. How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor. Structure 2022; 30: 1098-108.e1096.
 
8.
Deleyto-Seldas N, Efeyan A. The mTOR–autophagy axis and the control of metabolism. Front Cell Dev Biol 2021; 9: 655731.
 
9.
Aghanoori MR, Smith DR, Shariati-Ievari S, et al. Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes. Mol Metab 2019; 20: 149-65.
 
10.
Park JM, Lee DH, Kim DH. Redefining the role of AMPK in autophagy and the energy stress response. Nat Commun 2023; 14: 2994.
 
11.
Yue J, Aobulikasimu A, Sun W, Liu S, Xie W, Sun W. Targeted regulation of FoxO1 in chondrocytes prevents age-related osteoarthritis via autophagy mechanism. J Cell Mol Med 2022; 26: 3075-82.
 
12.
Xu K, Zhu W, Xu A, et al. Inhibition of FOXO1 mediated autophagy promotes paclitaxel induced apoptosis of MDA MB 231 cells. Mol Med Rep 2022; 25: 72.
 
13.
Zhang D, Wang W, Sun X, et al. AMPK regulates autophagy by phosphorylating BECN1 at threonine 388. Autophagy 2016; 12: 1447-59.
 
14.
White SJ, Chong JJH. Growth factor therapy for cardiac repair: an overview of recent advances and future directions. Biophys Rev 2020; 12: 805-15.
 
15.
Obradovic M, Sudar-Milovanovic E, Gluvic Z, Banjac K, Rizzo M, Isenovic ER. The Na(+)/K(+)-ATPase: a potential therapeutic target in cardiometabolic diseases. Front Endocrinol 2023; 14: 1150171.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top